Despite large first-quarter gains, 2 big Dow stocks show strong monthly chart formations and are worthy of new buying.
The generics drugmaker plans to tackle AstraZeneca's blockbuster antipsychotic drug Seroquel next.
Global food giant Nestle looks good.
In the current climate, a good defense can be your best offense.
This monthly scan is helpful for identifying which stocks may be too risky for new buying. It also turns up a pair of compelling 'buy' candidates.
Despite generic competition, the pharmaceutical giant beat Wall Street estimates, yet trimmed 2012 forecast.
Some of the biggest and highest-yielding drug stocks are declining near attractive buy levels.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
For years, Todd Mills pushed Frito-Lay to make taco shells from Doritos. He died from a brain tumor on Thanksgiving.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Which store penalizes you for too many returns? And which one will let you retroactively apply coupons?
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.